Marshall Urist

Insider Reports History

Location
New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact, for Marshall Urist
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marshall Urist:

Company Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP, Research & Investments Class A Ordinary Shares 27,368 $1,057,499 $38.64 11 Feb 2026 Direct
Royalty Pharma plc EVP, Research & Investments Class A Ordinary Shares 19,020 $734,932 $38.64 11 Feb 2026 By IRA
Royalty Pharma plc EVP, Research & Investments Class E Ordinary Shares 1,356,528 16 May 2025 Indirect
Royalty Pharma plc EVP, Research & Investments LP interests in RPI US Partners 2019, LP 247,412 07 Nov 2025 By Sandy Lamm LLC

Insider Reports Filed by Marshall Urist

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RPRX Royalty Pharma plc 11 Feb 2026 1 $0 4 EVP, Research & Investments 13 Feb 2026, 16:02
RPRX Royalty Pharma plc 30 Jan 2026 1 -$821,810 4 EVP, Research & Investments 02 Feb 2026, 16:59
RPRX Royalty Pharma plc 23 Jan 2026 1 -$805,110 4 EVP, Research & Investments 26 Jan 2026, 16:10
RPRX Royalty Pharma plc 16 Jan 2026 1 -$790,346 4 EVP, Research & Investments 20 Jan 2026, 17:00
RPRX Royalty Pharma plc 09 Jan 2026 1 -$815,634 4 EVP, Research & Investments 13 Jan 2026, 17:37
RPRX Royalty Pharma plc 02 Jan 2026 1 -$769,650 4 EVP, Research & Investments 06 Jan 2026, 16:17
RPRX Royalty Pharma plc 26 Dec 2025 1 -$786,380 4 EVP, Research & Investments 29 Dec 2025, 16:58
RPRX Royalty Pharma plc 19 Dec 2025 1 -$767,582 4 EVP, Research & Investments 22 Dec 2025, 16:09
RPRX Royalty Pharma plc 16 Dec 2025 1 -$766,420 4 EVP, Research & Investments 17 Dec 2025, 17:43
RPRX Royalty Pharma plc 05 Dec 2025 2 -$1,627,815 4 EVP, Research & Investments 09 Dec 2025, 17:00
RPRX Royalty Pharma plc 01 Dec 2025 2 -$1,659,489 4 EVP, Research & Investments 03 Dec 2025, 17:10
RPRX Royalty Pharma plc 05 Nov 2025 3 $0 4 EVP, Research & Investments 07 Nov 2025, 16:16
RPRX Royalty Pharma plc 06 Aug 2025 2 $0 4 EVP, Research & Investments 08 Aug 2025, 16:52
RPRX Royalty Pharma plc 16 May 2025 1 $0 4 EVP, Research & Investments 20 May 2025, 16:54
RPRX Royalty Pharma plc 08 May 2025 1 $0 4 EVP, Research & Investments 09 May 2025, 17:07
RPRX Royalty Pharma plc 12 Aug 2024 1 $0 4 EVP, Research & Investments 12 Aug 2024, 19:17
RPRX Royalty Pharma plc 22 Feb 2023 1 -$870,239 4 EVP, Research & Investments 24 Feb 2023, 17:26
RPRX Royalty Pharma plc 17 Feb 2023 2 $0 4 EVP, Research & Investments 17 Feb 2023, 15:57
RPRX Royalty Pharma plc 25 Jul 2022 2 -$1,007,446 4 EVP, Research & Investments 27 Jul 2022, 18:17
RPRX Royalty Pharma plc 24 Jun 2022 1 -$1,007,694 4 EVP, Research & Investments 24 Jun 2022, 17:19
RPRX Royalty Pharma plc 16 May 2022 1 -$929,836 4 EVP, Research & Investments 16 May 2022, 19:14
RPRX Royalty Pharma plc 11 May 2022 2 $0 4 EVP, Research & Investments 11 May 2022, 17:20
RPRX Royalty Pharma plc 04 Jun 2021 2 -$1,526,721 4 EVP & Co-Head of R&I 08 Jun 2021, 20:15
RPRX Royalty Pharma plc 02 Jun 2021 1 -$604,850 4 EVP & Co-Head Research & Inv. 04 Jun 2021, 18:52
RPRX Royalty Pharma plc 20 May 2021 2 -$82,159 4 EVP & Co-Head Research & Inv. 24 May 2021, 20:10
RPRX Royalty Pharma plc 07 May 2021 2 $0 4 EVP & Co-Head Research & Inv. 11 May 2021, 21:08